NCT06692673
Linaclotide for Colonoscopy Bowel Prep
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Trial terminated Sponsor's reason: terminated early due to futility/ineffectiveness Show 4 more changesShow less
- Eligibility criteria expanded, about 12 words
- Final enrollment: 4 participants (planned 10)
- Study completion date changed from estimate of Jul 28, 2026 to Apr 7, 2026
- Site details revised
Notable Trial status: Not Yet Recruiting to Recruitingv7 Show 4 more changesShow less
- Start date changed from estimate of Sep 1, 2025 to Dec 1, 2025
- Primary completion date: Dec 30, 2025 to Apr 30, 2026
- Study completion date: Feb 28, 2026 to Jul 28, 2026
- Site details revised
- Notable Start date: Jun 1, 2025 to Sep 1, 2025
- Primary completion date: Nov 30, 2025 to Dec 30, 2025
- Study completion date: Dec 31, 2025 to Feb 28, 2026
- Notable Start date: Mar 1, 2025 to Jun 1, 2025
- Primary completion date: Aug 31, 2025 to Nov 30, 2025
- Notable Start date: Jan 9, 2025 to Mar 1, 2025v4
Show 2 earlier versionsHide 2 earlier versions
- Notable Start date: Dec 1, 2024 to Jan 9, 2025v3
- Notable Phase: Early Phase 1 to Phase 1/2v2
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
BBPS a cutoff 6 or greater
Timeframe: Within 48 hours post Colonoscopy
Arms and interventions
Patients scheduled for ColonoscopyExperimental
Adult in-patients, 18 years of age and older, scheduled for an in-patient screening or diagnostic colonoscopy
Drugs: Use of Linaclotide as a single agent Colonoscopy prep
Sites
1 site in 1 country
- UF HealthGainesville, Florida, United States